Correlation Between Inhibrx and Surgical Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Surgical Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Surgical Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Surgical Science Sweden, you can compare the effects of market volatilities on Inhibrx and Surgical Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Surgical Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Surgical Science.

Diversification Opportunities for Inhibrx and Surgical Science

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Inhibrx and Surgical is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Surgical Science Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surgical Science Sweden and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Surgical Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surgical Science Sweden has no effect on the direction of Inhibrx i.e., Inhibrx and Surgical Science go up and down completely randomly.

Pair Corralation between Inhibrx and Surgical Science

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Surgical Science. In addition to that, Inhibrx is 2.35 times more volatile than Surgical Science Sweden. It trades about -0.05 of its total potential returns per unit of risk. Surgical Science Sweden is currently generating about 0.26 per unit of volatility. If you would invest  1,175  in Surgical Science Sweden on September 1, 2024 and sell it today you would earn a total of  100.00  from holding Surgical Science Sweden or generate 8.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy91.3%
ValuesDaily Returns

Inhibrx  vs.  Surgical Science Sweden

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Surgical Science Sweden 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Surgical Science is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Inhibrx and Surgical Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Surgical Science

The main advantage of trading using opposite Inhibrx and Surgical Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Surgical Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgical Science will offset losses from the drop in Surgical Science's long position.
The idea behind Inhibrx and Surgical Science Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes